B. R. Winterhalter - Concepedia

Author

B. R. Winterhalter

University of Freiburg

Also Known As

B. R. Winterhalter, B. Winterhalter, B.R. Winterhalter, Bernd R Winterhalter, Bernd R. Winterhalter, Bernd Winterhalter

Publications

494

Citations

H-Index

Concepts

All Affiliations

University of Freiburg University Medical Center Freiburg

About

B. R. Winterhalter is an author at University of Freiburg specializing in cancer research, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	267
2	Pharmacology	6	6	248
3	Cancer Therapeutics	5	5	194
4	Pathology	3	3	113
5	Immunology	1	1	19

B. R. Winterhalter

Publications

454

Citations

H-Index

Page 1

	Year	Citations
Synthesis, mechanism of action, and biological evaluation of mitosenes Eric Orlemans, Willem Verboom, M. W. Scheltinga, Journal of Medicinal Chemistry	1989	83
Enhancement of the antiproliferative activity of cis‐diamminedichloroplatinum(II) by quercetin Johann Hofmann, Heiner Fiebig, B. R. Winterhalter, International Journal of Cancer	1990	82
Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts Catherine C. Scholz, Dietmar Berger, B. R. Winterhalter, European Journal of Cancer and Clinical Oncology Tumor BiologyOncologyMedicineDrug ResponsePathology	1990	61
Combined In Vitro/In Vivo Test Procedure with Human Tumor Xenografts for New Drug Development Heinz‐Herbert Fiebig, Dietmar Berger, W. A. Dengler, Beiträge zur Onkologie/Contributions to oncology XenotransplantationOncologyHuman Tumor XenograftsMedicineTheranostics	1992	54
In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts Heinz‐Herbert Fiebig, Dietmar Berger, B. R. Winterhalter, Cancer Treatment Reviews Human Tumor XenograftsVivo EvaluationMedicineRadiopharmaceutical TherapyTumor Targeting	1990	39
The clonogenic assay with human tumor xenografts: Evaluation, predictive value and application for drug screening Dietmar Berger, H. Henß, B. R. Winterhalter, Annals of Oncology Tumor BiologyOncologyPreclinical Drug EvaluationHuman Tumor XenograftsCancer Detection	1990	34
Preclinical phase II study of ifosfamide in human tumour xenografts in vivo Dietmar Berger, Heinz H. Fiebig, B. R. Winterhalter, Cancer Chemotherapy and Pharmacology OncologyHuman Tumour XenograftsMedicinePathologyRadiopharmaceutical Therapy	1990	33
Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients T. Schilling, Heiner Fiebig, Sándor Kerpel‐Fronius, Investigational New Drugs OncologySingle Intravenous BolusMedicineMetronomic TherapyClinical Phase	1996	27
A Phase-II Study with Idarubicin, Ifosfamide and VP-16 (IIVP-16) in Patients with Refractory or Relapsed Aggressive and High Grade non-Hodgkin's Lymphoma Andreas Engert, R. Schnell, F. Kñpper, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyLymphoid NeoplasiaPhase-ii StudyMedicineImmunodeficiencies	1997	19
In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET‐18‐OCH<sub>3</sub> and thioether lipid BM 41.440 Gerhard Leder, Heinz‐Herbert Fiebig, E. Wallbrecher, Lipids	1987	12

Page 1